Search results
Results from the WOW.Com Content Network
Somatostatin, also known as growth hormone-inhibiting hormone (GHIH) or by several other names, is a peptide hormone that regulates the endocrine system and affects neurotransmission and cell proliferation via interaction with G protein-coupled somatostatin receptors and inhibition of the release of numerous secondary hormones. Somatostatin ...
The main release-inhibiting hormones or inhibiting hormones are as follows: The hypothalamus uses somatostatin to tell the pituitary to inhibit somatotropin and to tell the gastrointestinal tract to inhibit various gastrointestinal hormones. There are various other inhibiting factors that also have tropic endocrine inhibition activity.
The somatostatin family is a protein family with somatostatin as titular member, a hormone which inhibits the release of the pituitary somatotropin (growth hormone) and inhibits the release of glucagon and insulin from the pancreas of fasted animals. Cortistatin is a cortical neuropeptide with neuronal depressant and sleep-modulating properties ...
It is a non-selective somatostatin receptor antagonist, [37] inhibiting the effects of somatostatin on target cells in the gastrointestinal tract, pancreas, hypothalamus, and central nervous system. [2] Cyclosomatostatin is used as a research chemical to investigate the effects of somatostatin on different cell types by antagonizing its ...
Somatostatin: Pancreatic δ Cells: 1) Suppresses glucagon release from α cells (acts locally); 2) Suppresses release of Insulin, Pituitary tropic hormones, gastrin and secretin. 3) Decreases stomach acid production by preventing the release of other hormones (gastrin and histamine), thus slowing down the digestive process. Lowers [citation needed]
In beta cells, insulin release is stimulated primarily by glucose present in the blood. [4] As circulating glucose levels rise such as after ingesting a meal, insulin is secreted in a dose-dependent fashion. [4] This system of release is commonly referred to as glucose-stimulated insulin secretion (GSIS). [10]
Pain in the lower left abdomen may be caused by several different conditions. Experts explain.
Cyclosomatostatin is one such compound. Contrary to previously discussed compounds, cyclosomatostatin does not contain a radionuclide. It is a non-selective somatostatin receptor antagonist, [36] inhibiting the effects of somatostatin on target cells in the gastrointestinal (GI) tract, pancreas, hypothalamus, and central nervous system (CNS). [2]